A rare missense variant that protects against asthma

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in the Journal of Allergy and Clinical Immunology reporting a rare missense variant in STAT6 that protects against asthma. Kari Stefansson, Gudmundur Nordahl, Thorunn A....

New Study Explores the Role of BMI in Disease Risk

A new study from deCODE genetics/Amgen highlights the importance of BMI in the pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases. Kari Stefansson and Guðmundur Einarsson, scientists at deCODE genetics and authors on...

Discovery of cancer risk associations for six novel genes

Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title “Gene-based burden tests of rare germline...

Eric K. Fernström Nordic Prize to Genetics Pioneer

Grant and Award Announcement Lund University Kári Stefánsson, professor at the University of Iceland and CEO of deCODE genetics, has been awarded one of the Nordic region’s most prestigious medical awards –Eric K. Fernström Foundation Nordic Prize. His work has...

Sequence variants that affect IgG subclass levels

Kari Stefansson CEO of decode genetics and senior author on the paper with Thorunn A. Olafsdottir first author on the paper. Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Nature Communications reporting sequence...